AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACDC Metals Ltd

0.044

0.000

Volume:- -

Turnover:588.76

Market Cap:5.28M

PE:-2

High:0.044

Open:0.044

Low:0.044

Close:0.044

52wk High:0.160

52wk Low:0.037

Shares:119.96M

Float Shares:64.42M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.022

EPS(LYR):-0.009

ROE:-17.69%

ROA:-8.80%

PB:0.59

PE(LYR):-4.67

Loading ...

Overview Company News Filings

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline

Ultra Maritime Secures New Contract to Strengthen Royal Australian Navy's Undersea Defence Capabilities

ACDC Metals Ltd-Exploration Program at Mount Jackson Gold Project Commences

THOMSON REUTERS

Is Agree Realty (ADC) Price Fair After Steady Returns And Shifting REIT Sentiment

Simply Wall St.

ACDC Metals Ltd-ACDC Metals Acquires Gold-Silver Project Walker Lane Nevada

THOMSON REUTERS

BRIEF-ACDC Metals Seeks Trading Halt

ACDC Metals Ltd - Trading Halt Pending Material Capital Raising and Project Acquisition Announcement

THOMSON REUTERS

Agree Realty Outpacing Internal Targets After Strong Start, RBC Says

MT Newswires Live

Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine

GUIDANCE: (ADC) Agree Realty Expects 2026 Adjusted FFO Range $4.54-$4.58, vs. FactSet Est of $4.56

MT Newswires Live

Earnings Flash (ADC) Agree Realty Posts Q1 Adjusted FFO $1.14, vs. FactSet Est of $1.11

MT Newswires Live

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Is It Time To Reassess Agree Realty (ADC) After Its Recent Share Price Pullback?

Simply Wall St.

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/ADC.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ADC.AU\",,,,,undefined,":{"symbol":"ADC.AU","market":"AU","secType":"STK","nameCN":"ACDC Metals Ltd","latestPrice":0.044,"timestamp":1789606904653,"preClose":0.044,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"ACDC Metals Ltd","floatShares":64416493,"shares":119964226,"eps":-0.022,"marketStatus":"Trading","change":0,"latestTime":"09-17 11:01:44 AEST","open":0.044,"high":0.044,"low":0.044,"amount":588.764,"amplitude":0,"askPrice":0.045,"askSize":10000,"bidPrice":0.044,"bidSize":10248,"shortable":3,"etf":0,"ttmEps":-0.022,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789624800000},"marketStatusCode":2,"adr":0,"listingDate":1673787600000,"exchange":"ASX","adjPreClose":0.044,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ADC.AU","preClose":0.047,"auctionPrice":0.044,"auctionVolume":65977,"auction":3,"marketStatus":"盘后竞价","timestamp":1788760800923}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ADC.AU\",,,,,undefined,":{"symbol":"ADC.AU","floatShares":64416493,"roa":"-8.80%","roe":"-17.69%","lyrEps":-0.00943,"shares":119964226,"dividePrice":0,"high":0.044,"amplitude":0,"preClose":0.044,"low":0.044,"week52Low":0.037,"pbRate":"0.59","psRate":"15.32","week52High":0.16,"institutionHeld":0,"latestPrice":0.044,"committee":0.012248,"eps":-0.022,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.022,"open":0.044,"prevYearClose":0.065,"prevWeekClose":0.044,"prevMonthClose":0.046,"prevQuarterClose":0.038,"fiveDayClose":0.044,"twentyDayClose":0.042,"sixtyDayClose":0.041},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636899893","title":"Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899893","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899893?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:00","pubTimestamp":1779235200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, May 20, 2026 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that Dr. Bing Hou has been appointed Chief Scientific Officer, reporting directly to Dr. Jay Mei, Founder, Chairman, and Chief Executive Officer of Antengene.Dr. Hou's appointment underscores Antengene's commitment to strengthening its innovation-driven R&D model as a global biotech company. In this role, Dr. Hou will lead Antengene's efforts across Drug Discovery, Translational Medicine, and Chemistry, Manufacturing and Controls , with a focus on deepening the Company's research engine and building a pipeline of next-generation therapeutic candidates with transformational potential.\"I am honored and excited to step into the role of Chief Scient","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-appoints-dr-bing-hou-as-chief-scientific-officer-to-lead-innovation-driven-rd-strategy-and-advance-next-generation-pipeline-302776389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","CMC","LU0971096721.USD","CRS.AU","LU0963586101.USD","LU0882574139.USD","BK4006","LU2065731478.USD","CRS","LU2237443382.USD","IND.AU","IE00B66KJ199.SGD","DBB","LU2237443622.USD","LU0170899867.USD","IE00BZ1G4Q59.USD","BK4080","LU0267386448.USD","IE00BKVL7J92.USD","LU2237443895.HKD","LU2746668461.USD","LU0149725797.USD","BK4187","IE00BFXG1179.USD","IE0031619046.USD","LU2746668974.SGD","LU2237443978.SGD","ADC.AU","IE00B7SZL793.SGD","IND","IE00B1BXHZ80.USD","IE00B19Z4B17.USD","IE00BHPRN162.USD","BK7095","BK4231","ADC","LU2237443465.HKD","LU1363072403.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636867785","title":"Ultra Maritime Secures New Contract to Strengthen Royal Australian Navy's Undersea Defence Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2636867785","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636867785?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:00","pubTimestamp":1779228000,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia, May 20, 2026 /PRNewswire/ -- Ultra Maritime Australia has been awarded a contract by the Australian Department of Defence to supply Acoustic Device Countermeasure  units in support of the Royal Australian Navy. This latest agreement reinforces a trusted partnership spanning more than a decade, during which Ultra Maritime has consistently delivered advanced torpedo defence expendables to the Commonwealth of Australia.Ultra Maritime is the world’s leading provider of advanced acoustic countermeasures, delivering innovation, evolution and operational advantage to allied navies. . Ultra Maritime's ADC systems are engineered to provide mission-ready performance in the most demanding operational environments. Featuring intelligent acoustic output and proven interoperability, these systems are deployed by navies around the world as a reliable layer of defence against evolving undersea threats.This latest contract further strengthens Ultra Maritime's role in supporting Aus","market":"us","thumbnail":"https://mma.prnewswire.com/media/2983057/Sea_Deceptor_Ultra_Maritime.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2983057/Sea_Deceptor_Ultra_Maritime.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ultra-maritime-secures-new-contract-to-strengthen-royal-australian-navys-undersea-defence-capabilities-302776045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","LU0345780521.USD","OZF.AU","ADC","BK4080","XAO.AU","IMLC.AU","IOZ.AU","SLF.AU","ZYAU.AU","BK4017","QFN.AU","IISV.AU","E200.AU","BK4585","BK4588","BK7062","VAS.AU","DACE.AU","BBOZ.AU","ADC.AU","VAP.AU","BK4231","IIGF.AU","XJO.AU","QRE.AU","OZR.AU","RGLD","EIGA.AU","GIVE.AU","GEAR.AU","ASW.AU","BK7095","LU0345780281.USD","STW.AU","BEAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634422781","title":"ACDC Metals Ltd-Exploration Program at Mount Jackson Gold Project Commences","url":"https://stock-news.laohu8.com/highlight/detail?id=2634422781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634422781?lang=en_us&edition=fundamental","pubTime":"2026-05-11 08:09","pubTimestamp":1778458182,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUER7V2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADC.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126004","title":"Is Agree Realty (ADC) Price Fair After Steady Returns And Shifting REIT Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126004","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633126004?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:46","pubTimestamp":1778161578,"startTime":"0","endTime":"0","summary":"If you are wondering whether Agree Realty stock at around US$76.50 offers good value today, this breakdown will help you judge whether the current price lines up with the underlying fundamentals.\nRecent returns have been steady, with the stock showing 0.2% over the past week, 1.3% over the last month, 6.1% year to date, 4.7% over 1 year, 29.8% over 3 years and 40.3% over 5 years.\nRecent news coverage has centered on Agree Realty in the context of broader real estate market sentiment and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-agree-realty-adc-price-fair-after-steady-returns-and-shif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-agree-realty-adc-price-fair-after-steady-returns-and-shif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADC.AU","BK4080","BK7095","DCF","CFA.SI","REIT","ADC","BK4231","BK6142","8C8U.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631260575","title":"ACDC Metals Ltd-ACDC Metals Acquires Gold-Silver Project Walker Lane Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2631260575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631260575?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:09","pubTimestamp":1777507744,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUE7XLZNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ADC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630344728","title":"BRIEF-ACDC Metals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2630344728","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630344728?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:10","pubTimestamp":1777338656,"startTime":"0","endTime":"0","summary":"BRIEF-ACDC Metals Seeks Trading HaltApril 28 (Reuters) - ACDC Metals Ltd ADC.AX:TRADING HALT PENDING MATERIAL CAPITAL RAISING AND PROJECT ACQUISITION ANNOUNCEMENTFurther company coverage: ADC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41A1BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630834904","title":"ACDC Metals Ltd - Trading Halt Pending Material Capital Raising and Project Acquisition Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630834904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630834904?lang=en_us&edition=fundamental","pubTime":"2026-04-28 08:11","pubTimestamp":1777335062,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41A1BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ADC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629685956","title":"Agree Realty Outpacing Internal Targets After Strong Start, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2629685956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629685956?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:04","pubTimestamp":1776960295,"startTime":"0","endTime":"0","summary":"Agree Realty  is running ahead of its internal plan across most key metrics, supported by a strong start to the year, RBC Capital Markets said Wednesday in a report.Robust early-year deal flow has the company positioned to reach the high end of its full-year investment plan, the report said. RBC raised its 2026 and 2027 AFFO estimates by $0.02 each, citing better expenses, stronger percentage-rent performance, and a slightly improved cost of capital.Management continues to describe the acquisition environment as highly favorable, with pipelines at record levels and deal activity expected to accelerate through Q3, RBC said. Annual returns on property remain stable, the competitive landscape is steady, and tenant relationships continue to expand, the report said.RBC raised its price target on Agree Realty stock to $82 from $81 and maintained its outperform rating.Price: 76.84, Change: +0.17, Percent Change: +0.22","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","ADC.AU","BK4231","ADC","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629617570","title":"Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2629617570","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629617570?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:00","pubTimestamp":1776816000,"startTime":"0","endTime":"0","summary":"SHANGHAI, April 22, 2026 /PRNewswire/ -- Mabwell , an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on its self-developed novel Nectin-4 ADC  for the treatment of cervical cancer has been published in The New England Journal of Medicine, a leading international medical journal.ADCs are hailed as \"magic bullets\" for precisely targeting tumors. Previously, pseudoprogression has been predominantly observed in immunotherapies such as PD1/PDL1 inhibitors, whereas its occurrence in ADC therapy for solid tumors is considered exceedingly rare. This finding by Dr. Wang Shanbing's team carries significant implications for the clinical management of advanced cervical cancer. The article strongly emphasizes that treatment that could prolong life should not be prematurely discontinued based solely on ra","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/case-report-of-mabwells-nectin-4-targeting-adc-9mw2821-in-cervical-cancer-published-in-the-new-england-journal-of-medicine-302749067.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK0239","688062","BK4231","SCC","ADC.AU","BK7095","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629105090","title":"GUIDANCE: (ADC) Agree Realty Expects 2026 Adjusted FFO Range $4.54-$4.58, vs. FactSet Est of $4.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2629105090","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629105090?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:19","pubTimestamp":1776802797,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ADC) Agree Realty Expects 2026 Adjusted FFO Range $4.54-$4.58, vs. FactSet Est of $4.56","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","ADC","BK4080","BK4231","ADC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629050908","title":"Earnings Flash (ADC) Agree Realty Posts Q1 Adjusted FFO $1.14, vs. FactSet Est of $1.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2629050908","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629050908?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:18","pubTimestamp":1776802696,"startTime":"0","endTime":"0","summary":"Earnings Flash (ADC) Agree Realty Posts Q1 Adjusted FFO $1.14, vs. FactSet Est of $1.11","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC.AU","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627446509","title":"Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules","url":"https://stock-news.laohu8.com/highlight/detail?id=2627446509","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627446509?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:00","pubTimestamp":1776168000,"startTime":"0","endTime":"0","summary":"Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3. Achieves 10x improvement in absolute molar mass andextended sizing, without compromising resolutionor analytical throughput.2. Reduces sample consumption by 30-50% and solvent use by approximately 40%.3. MILFORD, Mass., April 14, 2026 /PRNewswire/ --Waters Corporation  today announced the launch of the Waters omniDAWNMulti-Angle Light Scattering  Photometer, part of the Wyatt Technology Portfolio. Featuring 18 angles of detection, the omniDAWN Photometer is the first extended-range MALS detector for Ultra High Performance Liquid Chromatography  and Ultra Performance Liquid Chromatography  workflows, delivering absolute molar mass and size measurements without compromising resolution or throughput.The omniDAWN MALS Photometer extends UPLC-compatible sizing ten-fold, enabling reliable characterization of more complex analytes including large molecules and a","market":"other","thumbnail":"https://mma.prnewswire.com/media/2955292/omniDAWN_Hero_Image.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2955292/omniDAWN_Hero_Image.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/waters-debuts-industry-first-extended-range-mals-detector-for-uhplcuplc-powering-rapid-characterization-of-large-molecules-302741278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374615.EUR","LU2413666426.HKD","LU0347712357.USD","LU0690374961.EUR","GB00B4LPDJ14.GBP","LU2404859741.USD","BK4231","BK4585","GB00B4QBRK32.GBP","BK4588","WAT","LU2413666699.HKD","BK4121","LU2404859667.USD","BK7095","BK4080","LU1721428933.USD","ADC","ADC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625646189","title":"Is It Time To Reassess Agree Realty (ADC) After Its Recent Share Price Pullback?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625646189","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625646189?lang=en_us&edition=fundamental","pubTime":"2026-04-05 15:29","pubTimestamp":1775374164,"startTime":"0","endTime":"0","summary":"Wondering if Agree Realty at around US$76.61 is offering fair value or a potential bargain, especially after a solid multi year run? This article breaks down what the current price may be implying.\nThe stock recently closed at US$76.61, with returns of 3.0% over 7 days, a 5.8% decline over 30 days, 6.2% year to date, 7.3% over 1 year, 31.2% over 3 years and 39.6% over 5 years. This gives you a mixed picture across different timeframes.\nRecent coverage around Agree Realty has focused on its...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-it-time-to-reassess-agree-realty-adc-after-its-recent-sha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/is-it-time-to-reassess-agree-realty-adc-after-its-recent-sha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADC","ADC.AU","DCF","BK4231","BK4080","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624551293","title":"NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2624551293","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624551293?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:00","pubTimestamp":1774998000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and TOKYO, April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. , a leading provider of integrated drug discovery and development services and Ajinomoto BioPharma Services , a leading provider of biopharmaceutical manufacturing services and platform technologies, today announced a research collaboration to expand access to AJICAP, Aji BioPharma's sitespecific conjugation platform for NJ Bio's discoverystage and early development clients. This collaboration broadens NJ Bio's advanced antibody conjugation and linker capabilities, supporting the development of nextgeneration antibody–drug conjugates  and other targeted therapeutics.This partnership will expand access to nextgeneration antibody conjugation capabilities for biopharma innovators. Through the collaboration, NJ Bio will integrate the AJICAP platform into its discovery and development workflows, offering clients a robust and highly reproducible approach for sitespecific conjugation of cytotoxic and noncytotoxic payloads t","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2947092/Bio_Aji_BioPharma_Services_Collaboration.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2947092/Bio_Aji_BioPharma_Services_Collaboration.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/nj-bio-inc-and-ajinomoto-biopharma-services-enter-into-collaboration-to-strengthen-support-for-antibodydrug-conjugate-development-302730700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC.AU","BK4139","BK4080","BK7095","CDMO","ADC","BK4231","CRO.AU","BK7500"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}